What one share of Abeona Therapeutics holds
Abeona Therapeutics’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $0.41 |
|---|---|
| Profit | −$1.06 |
| Capex (buildings and equipment) | $0.08 |
| Free cash flow | −$1.31 |
| Cash and investments | $0.98 |
| Debt | $0.26 |
| Book value | $2.24 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2010 | $38.67 | −$750.00 | $0.56 | −$552.13 | — | −$1,360 |
| 2011 | $115.03 | −$269.35 | $2.50 | −$478.46 | — | −$921.18 |
| 2012 | $227.68 | −$647.83 | $0.67 | −$205.14 | — | −$863.05 |
| 2013 | $100.20 | $76.11 | $0.10 | −$0.05 | — | −$718.00 |
| 2014 | $11.90 | −$381.55 | $0.00 | −$20.73 | — | — |
| 2015 | $2.28 | −$13.16 | $0.28 | −$9.72 | — | $51.71 |
| 2016 | $0.65 | −$16.00 | $0.38 | −$9.90 | — | $61.54 |
| 2017 | $0.50 | −$16.40 | $0.52 | −$14.12 | — | $90.69 |
| 2018 | $1.58 | −$29.81 | $4.86 | −$25.43 | — | $69.90 |
| 2019 | — | −$37.87 | $3.13 | −$34.32 | — | $53.34 |
| 2020 | $2.70 | −$22.73 | $0.36 | −$9.81 | — | $26.67 |
| 2021 | $0.76 | −$21.57 | $1.05 | −$17.73 | — | $7.20 |
| 2022 | $0.18 | −$5.53 | $0.02 | −$5.55 | — | — |
| 2023 | $0.16 | −$2.54 | $0.02 | −$1.75 | — | $0.56 |
| 2024 | — | −$1.55 | $0.06 | −$1.42 | — | $0.96 |
| 2025 | $0.09 | $1.01 | $0.12 | −$1.27 | — | $2.89 |
Common questions about Abeona Therapeutics
How much does one share of Abeona Therapeutics earn?
Over the last 12 months, Abeona Therapeutics lost $1.06 for each share on $0.41 of sales.
Does Abeona Therapeutics pay a dividend?
Abeona Therapeutics didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Abeona Therapeutics’s book value per share?
Abeona Therapeutics’s book value is $2.24 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Abeona Therapeutics have?
Each share of Abeona Therapeutics has $0.98 of cash and investments and $0.26 of debt, as of June 30, 2026.
What is Abeona Therapeutics’s free cash flow per share?
−$1.31 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has Abeona Therapeutics bought back shares?
Abeona Therapeutics’s share count rose about 531652% from 2010 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.